🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Could a focus on B cells improve immunotherapies? Three studies now suggest that it might go.nature.com/2tqc9qC

Corine Bertolotto, Directrice d'un laboratoire Inserm "Le #cancer continue de sévir pendant la tourmente et fait plus de 150 000 morts rien qu'en France. Malgré la crise, il ne faut pas relâcher nos efforts dans le domaine de la #recherche en cancérologie." @CorineNice #COVID19

Aidez la recherche contre le #cancer, le soutien aux patientes et patients et à leurs proches. Faites un #don sur don.ligue-cancer.net Nous avons besoins de vous !

Type II RAFi + allosteric MEKi prevents and overcomes resistance in cancers with #KRAS, #NRAS #NF1 or #BRAF mutations. This combo expands activated/exhausted CD8+ T cells and can be reinvigorated by anti–PD-L1 therapy. Aayoung Hong et al. Cancer Discovery cancerdiscovery.aacrjournals.org/content/11/3/7…

ICYM: Check out our recent review on "Cell-intrinsic mechanisms of drug tolerance to systemic therapies in cancer" Molecular Cancer Research CRCL Centre Leon Berard camille.leonce mcr.aacrjournals.org/content/early/…

New #JITC article: ZEB1 transcription factor promotes immune escape in melanoma bit.ly/37ypbX7 Julie Caramel

It was a pleasure working with Sandra Ortiz-Cuaran and Hasan Korkaya on our editorial & special research topic on the EMT program as a regulator of the anti-tumor immune response for Frontiers - Immunology . A big thank-you to our contributing authors! Mohit Kumar Jolly Stéphane TERRY, PhD Julie Caramel

📢 Don't miss the opportunity to participate in one of the most important cancer conferences to be held in France this year ! #CancerResearch #CRCLSymposium #Cancerconference

📢#postdocposition available in the "Cancer cell plasticity in melanoma" lab headed by Dr. J.Caramel & Pr S.Dalle. 🔍Deciphering the crosstalk between tumor and immune cells mediating resistance to immunotherapy in metastatic melanoma ➡️tinyurl.com/2p98w336 #CancerResearch

Post-doc position available in my lab, candidatures are still welcome.

Fantastic study from ⁦MarineLab⁩ on the cellular hierarchy that governs melanoma growth and metastasis demonstrated by lineage tracing. Congratulations to all the authors and very honored to be part of this beautiful study. nature.com/articles/s4158…

🚨CRCL LECTURE🚨 We are honoured to receive Florian Rambow from UME-IKIM ! 📅Friday, June 16th He will talk to us about "Lessons from melanoma ecosystem" #Melanoma

Delighted to share our new publication in @nature describing the first pharmacological approach that targets EMT, decreases metastasis and sensitizes cancer cells to chemotherapy in preclinical models of tumor with EMT nature.com/articles/s4158…

🚨Registration is now open🚨 🎯6th CRCL International Cancer Symposium 🗓️January 29-31, 2025 📍 Lyon, France ➡️crclsymposium2025.fr Don't miss the opportunity to participate in one of the most important conferences about oncology research to be held in France.

⏰ Only 10 days left to submit an abstract and benefit from the early registration fees ! #CRCLSymposium

Join us this Friday, December 13th for the 9th CRCL Thematic Day to talk about #Epigenetics in oncogenesis: driver, passenger or both? With Giacomo Cavalli from InstituteHumGenetics, Céline Vallot from Institut Curie and Trevor Graham from Centre for Evolution and Cancer, ICR The ICR This event is open to all!